Expression of CD44 splice variants in colorectal cancer

British Journal of Surgery

Volumn 84, Issue 3, 1997, Pages 363-367

  Wong, L S ^a,c   Cantrill, J E ^b   Morris, A G ^b   Fraser, I A ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANTIGENS, CD44; AUTORADIOGRAPHY; BLOTTING, SOUTHERN; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MALE; POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 0030980675     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840328     Document Type: Article

References (19)

1. Jalkanen ST, Bargatze RF, Herron LR, Butcher EC. A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 1986; 16: 1195-202.
2. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992; 267: 4732-9.
3. Sereaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 1992; 89: 12 160-4.
4. Gunthert U, Hofmann M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
5. Seiter S, Arch R, Reher R et al. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993; 177: 443-55.
6. Jalkanen S, Joensuu H, Soderstrom K-O, Klemi P. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invest 1991; 87: 1835-40.
7. Tanabe KK, Ellis LM, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993; 341: 725-6.
8. Wielenga VJM, Heider K-H, Offerhaus GJ et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 53: 4754-6.
9. Matsumura Y, Hanbury D, Smith J, Tarin D. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 1994; 308: 619-24.
10. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
11. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340: 1053-8.
12. Haynes BF, Telen MJ, Hale LP, Denning SM. CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989; 10: 423-8.
13. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
14. Culty M, Miyake K, Kincade PW et al. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 1990; 111: 2765-74.
15. Jalkanan S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 1992; 116: 817-25.
16. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type 1 collagen-mediated melanoma cell mobility and invasion. J Cell Biol 1992; 116: 521-31.
17. Hasegawa Y, Takeda S, Ichii S et al. Detection of K-RAS mutations in DNAs isolated from feces of patients with colorectal tumours by mutant-allele-specific amplification (MASA). Oncogene 1995; 10: 1441-5.
18. Smith-Ravin J, England J, Talbot IC, Bodmer W. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 1995; 36: 81-6.
19. Arch R, Wirth K, Hofmann M et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992; 257: 682-5.